NO953242D0 - Fremgangsmåte for å forhindre eller inhibere fertilisering - Google Patents

Fremgangsmåte for å forhindre eller inhibere fertilisering

Info

Publication number
NO953242D0
NO953242D0 NO953242A NO953242A NO953242D0 NO 953242 D0 NO953242 D0 NO 953242D0 NO 953242 A NO953242 A NO 953242A NO 953242 A NO953242 A NO 953242A NO 953242 D0 NO953242 D0 NO 953242D0
Authority
NO
Norway
Prior art keywords
preventing
procedure
inhibiting fertilization
fertilization
inhibiting
Prior art date
Application number
NO953242A
Other languages
English (en)
Other versions
NO307916B1 (no
NO953242L (no
Inventor
Gary D Hodgen
Original Assignee
Hampton Roads Medical College
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hampton Roads Medical College filed Critical Hampton Roads Medical College
Publication of NO953242L publication Critical patent/NO953242L/no
Publication of NO953242D0 publication Critical patent/NO953242D0/no
Publication of NO307916B1 publication Critical patent/NO307916B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • Diabetes (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
  • Catching Or Destruction (AREA)
  • Pens And Brushes (AREA)
  • Fertilizers (AREA)
  • Fats And Perfumes (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
NO953242A 1993-02-19 1995-08-17 Anvendelse av en progesteronreseptorantagonist og kit med innhold derav NO307916B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/019,791 US5516769A (en) 1993-02-19 1993-02-19 Method of inhibiting fertilization
PCT/US1994/001804 WO1994018982A1 (en) 1993-02-19 1994-02-18 Method of preventing or inhibiting fertilization

Publications (3)

Publication Number Publication Date
NO953242L NO953242L (no) 1995-08-17
NO953242D0 true NO953242D0 (no) 1995-08-17
NO307916B1 NO307916B1 (no) 2000-06-19

Family

ID=21795040

Family Applications (1)

Application Number Title Priority Date Filing Date
NO953242A NO307916B1 (no) 1993-02-19 1995-08-17 Anvendelse av en progesteronreseptorantagonist og kit med innhold derav

Country Status (24)

Country Link
US (1) US5516769A (no)
EP (2) EP1159965B1 (no)
JP (1) JP3054780B2 (no)
KR (1) KR100232833B1 (no)
AT (2) ATE286734T1 (no)
AU (1) AU692150B2 (no)
BG (1) BG62431B1 (no)
BR (1) BR9406666A (no)
CA (1) CA2156493C (no)
CZ (1) CZ294325B6 (no)
DE (2) DE69430732T2 (no)
DK (2) DK1159965T3 (no)
ES (1) ES2231356T3 (no)
FI (1) FI114687B (no)
HU (1) HU221162B1 (no)
NO (1) NO307916B1 (no)
NZ (1) NZ262998A (no)
PL (1) PL175440B1 (no)
PT (2) PT684825E (no)
RO (1) RO118565B1 (no)
RU (1) RU2139055C1 (no)
SK (1) SK282068B6 (no)
UA (1) UA41351C2 (no)
WO (1) WO1994018982A1 (no)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX9301121A (es) 1992-03-02 1993-09-01 Schering Ag Metodo y equipo para la contracepcion oral y regulacion de la menstruacion con estrogeno/progestina/aniprogestina.
US7704983B1 (en) 1992-03-02 2010-04-27 Eastern Virginia Medical School Antiprogestin method for reducing side effects associated with low dosage HRT and oral contraception
US5439913A (en) 1992-05-12 1995-08-08 Schering Aktiengesellschaft Contraception method using competitive progesterone antagonists and novel compounds useful therein
DE4344463A1 (de) * 1993-12-22 1995-06-29 Schering Ag Kombinationsprodukt zur Kontrazeption
AU781835B2 (en) 1999-08-31 2005-06-16 Schering Aktiengesellschaft Mesoprogestins (progesterone receptor modulators) as a component of female contraceptives

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3890356A (en) * 1973-03-26 1975-06-17 Richardson Merrell Inc 7-Alkyl-{66 {hu 3,5{b -steroids
US4000273A (en) * 1973-11-01 1976-12-28 Richardson-Merrell Inc. Method for the control of fertility
US3928398A (en) * 1973-11-01 1975-12-23 Richardson Merrell Inc Derivatives of 7{60 -methylestr-4-en-3{60 ,17{62 -diol
US4416822A (en) * 1982-07-09 1983-11-22 The Upjohn Company 17β-Difluoromethyl steroids
IL68222A (en) * 1983-03-24 1987-02-27 Yeda Res & Dev Contraceptive compositions comprising a progesterone antagonist and a blocker of progesterone activity
AU572589B2 (en) * 1983-12-14 1988-05-12 Upjohn Company, The 11(alpha)-difluoromethyl and (e)-and (z)-11-fluoromethylene steroids
IE71203B1 (en) * 1990-12-13 1997-02-12 Akzo Nv Low estrogen oral contraceptives

Also Published As

Publication number Publication date
BG62431B1 (bg) 1999-11-30
PL310357A1 (en) 1995-12-11
EP1159965A3 (en) 2002-05-22
JPH08510992A (ja) 1996-11-19
US5516769A (en) 1996-05-14
KR960700726A (ko) 1996-02-24
RU2139055C1 (ru) 1999-10-10
NO307916B1 (no) 2000-06-19
PL175440B1 (pl) 1998-12-31
CZ205095A3 (en) 1996-01-17
PT1159965E (pt) 2005-03-31
NZ262998A (en) 1997-06-24
EP0684825B1 (en) 2002-06-05
NO953242L (no) 1995-08-17
CA2156493C (en) 2002-10-29
PT684825E (pt) 2002-10-31
WO1994018982A1 (en) 1994-09-01
AU6299294A (en) 1994-09-14
AU692150B2 (en) 1998-06-04
EP1159965A2 (en) 2001-12-05
FI953878A0 (fi) 1995-08-17
HUT72079A (en) 1996-03-28
EP0684825A1 (en) 1995-12-06
JP3054780B2 (ja) 2000-06-19
BG99867A (bg) 1996-04-30
DE69434239D1 (de) 2005-02-17
DE69434239T2 (de) 2006-03-30
DK1159965T3 (da) 2005-05-23
ATE218347T1 (de) 2002-06-15
KR100232833B1 (ko) 1999-12-01
UA41351C2 (uk) 2001-09-17
RO118565B1 (ro) 2003-07-30
DK0684825T3 (da) 2002-07-15
CA2156493A1 (en) 1994-09-01
SK282068B6 (sk) 2001-10-08
FI953878A (fi) 1995-08-17
HU221162B1 (en) 2002-08-28
DE69430732D1 (de) 2002-07-11
FI114687B (fi) 2004-12-15
EP1159965B1 (en) 2005-01-12
ATE286734T1 (de) 2005-01-15
DE69430732T2 (de) 2002-10-24
CZ294325B6 (cs) 2004-11-10
BR9406666A (pt) 1996-01-23
ES2231356T3 (es) 2005-05-16
EP0684825A4 (en) 1998-01-14
SK101395A3 (en) 1997-04-09

Similar Documents

Publication Publication Date Title
ES2148476T3 (es) Derivados de azabicicloalcano n-substituidos como neurolepticos asf.
ES2114605T5 (es) Metodo anticonceptivo que emplea un antagonista de progesterona competitivo y nuevos compuestos utilizados en el.
FR2656521B1 (fr) Procede et dispositif pour melanger et administrer directement au point d'application un ciment osseux constitue de deux composes.
DE69620241D1 (de) Gonadotropin releasing hormon- antagonisten
NO921835L (no) Fremgangsmaate for fremstilling av amidinofenylalaninderivat samt anvendelse derav
PT687251E (pt) Derivados de 1,3-di-hidro-indol-2-ona, substituidos na posicao 3 por um grupo azoto , como agonistas ou antagonistas da vasopressina e/ou ocitocina
DE69325130D1 (de) N-sulfonyl-2-oxoindol-derivate mit einer affinität für die vasopressin und/oder ocytocin rezeptoren
DE69425655D1 (de) Antagonisten des fibrinogenrezeptors
AR015418A1 (es) Procedimiento para la preparacion de la forma cristalina (modificacion 1) de la n-(trifluormetil-fenil)-5-metil-isoxazol-4-carboxamida.
MX9801890A (es) Nuevos compuestos antagonistas selectivos del receptor nk3 humano, procedimiento para su obtencion y composiciones farmaceuticas que los contienen.
NO953242D0 (no) Fremgangsmåte for å forhindre eller inhibere fertilisering
ES2027391T3 (es) Procedimiento de preparacion de ureas sustituidas.
AU1037783A (en) Tetrazolyl substituted quinazolinones
DE59408506D1 (de) "Steroidzwischenprodukte und Verfahren zu ihrer Herstellung"
ES2091570T3 (es) Nuevos derivados peptidicos antagonistas de la bradiquidina, su procedimiento de preparacion y composiciones farmaceuticas que los contienen.
EP0418990A3 (en) 13-bromo and 13,14-dibromo ergoline, their preparation and their use
ES2032573T3 (es) Procedimiento de preparacion de derivados de 4,4-dimetil-tetrahidropir-2-ona.
PE105899A1 (es) Progestagenos cristalinos
AU3024289A (en) The use of monoclonal antibodies (mabs) as procedure control for immunometric assays

Legal Events

Date Code Title Description
MK1K Patent expired